tirzepatide and cancer 💊 Weight-loss drug shows cancer-fighting potential Researchers at the University of Michigan discovered that (Mounjaro, Zepbound), already FDA-approved for diabetes obesity, also shrinks breast tumors in obese mice. When Tirzepatide and Cancer Risk in

FDA submission is likely coming in 2026/2027 if the remaining readouts hold up Some other noteworthy drugs in the pipeline: Tirzepatide: The base drug is already approved for diabetes and obesity, but Lilly keeps expanding its label Kisunla (donanemab) for Alzheimer's Eloralintide: amylin receptor agonist heading to phase 3, at ADA it showed 20% weight loss on the amylin pathway alone MORF-057: bit of a wild card, after the $3.2 billion acquisition of Morphic

Adequate maternal nutrition is essential for maintaining milk production, and significant calorie restrictionwhether medication-induced or dietarymay potentially compromise lactation

Accessible clinical support is non-negotiable

Care at Home: Maintain a robust immune system with SkinCeuticals Immune Support supplements, which contain vitamins and minerals known to enhance immune function

I've never been an investor in a company thats got so much attention in a space thats got so much attention, says Arnardottir.

Carpal Tunnel Syndrome Carpal tunnel syndrome (CTS) is a condition that can develop with the use of growth hormone therapies